4.5 Article

Nitric oxide-GAPDH-Siah: A novel cell death cascade

Journal

CELLULAR AND MOLECULAR NEUROBIOLOGY
Volume 26, Issue 4-6, Pages 527-538

Publisher

SPRINGER/PLENUM PUBLISHERS
DOI: 10.1007/s10571-006-9011-6

Keywords

GAPDH; nitric oxide; nitric oxide synthase; S-nitrosylation; Siah; apoptosis; Parkinson's disease; Huntington's disease

Funding

  1. NIDA NIH HHS [DA00074, DA-00266] Funding Source: Medline

Ask authors/readers for more resources

1. Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) is an extremely abundant glycolytic enzyme, and exemplifies the class of proteins with multiple, seemingly unrelated functions. Recent studies indicate that it is a major intracellular messenger mediating apoptotic cell death. This paper reviews the GAPDH cell death cascade and discusses its clinical relevance. 2. A wide range of apoptotic stimuli activate NO formation, which S-nitrosylates GAPDH. The S-nitrosylation abolishes catalytic activity and confers upon GAPDH the ability to bind to Siah, an E3-ubiquitin-ligase, which translocates GAPDH to the nucleus. In the nucleus, GAPDH stabilizes the rapidly turning over Siah, enabling it to degrade selected target proteins and affect apoptosis. 3. The cytotoxicity of mutant Huntingtin (mHtt) requires nuclear translocation which appears to be mediated via a ternary complex of GAPDH-Siah-mHtt. The neuroprotective actions of the monoamine oxidase inhibitor R-(-)-deprenyl (deprenyl) reflect blockade of GAPDH-Siah binding. Thus, novel cytoprotective therapies may emerge from agents that prevent GAPDH-Siah binding.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available